Loss of the Putative Tumor Suppressor Band 4.1B/Dal1 Gene Is Dispensable for Normal Development and Does Not Predispose to Cancer

REFERENCES

• Chishti, A. H., A. C. Kim, S. M. Marfatia, M. Lutchman, M. Hanspal, H. Jindal, S. C. Liu, P. S. Low, G. A. Rouleau, N. Mohandas, J. A. Chasis, J. G. Conboy, P. Gascard, Y. Takakuwa, S. C. Huang, E. J. Benz, Jr., A. Bretscher, R. G. Fehon, J. F. Gusella, V. Ramesh, F. Solomon, V. T. Marchesi, S. Tsukita, K. B. Hoover, et al. 1998. The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem. Sci. 23:281–282.
   PubMed Web of Science ®Google Scholar
• Denisenko-Nehrbass, N., K. Oguievetskaia, L. Goutebroze, T. Galvez, H. Yamakawa, O. Ohara, M. Carnaud, and J. A. Girault. 2003. Protein 4.1B associates with both Caspr/paranodin and Caspr2 at paranodes and juxtaparanodes of myelinated fibres. Eur. J. Neurosci. 17:411–416.
   PubMedGoogle Scholar
• Gimm, J. A., X. An, W. Nunomura, and N. Mohandas. 2002. Functional characterization of spectrin-actin-binding domains in 4.1 family of proteins. Biochemistry 41:7275–7282.
   PubMed Web of Science ®Google Scholar
• Gutmann, D. H., J. Donahoe, A. Perry, N. Lemke, K. Gorse, K. Kittiniyom, S. A. Rempel, J. A. Gutierrez, and I. F. Newsham. 2000. Loss of DAL-1, a protein 4.1-related tumor suppressor, is an important early event in the pathogenesis of meningiomas. Hum. Mol. Genet. 9:1495–1500.
   PubMed Web of Science ®Google Scholar
• Gutmann, D. H., C. A. Haipek, S. P. Burke, C. X. Sun, D. R. Scoles, and S. M. Pulst. 2001. The NF2 interactor, hepatocyte growth factor-regulated tyrosine kinase substrate (HRS), associates with merlin in the “open” conformation and suppresses cell growth and motility. Hum. Mol. Genet. 10:825–834.
   PubMedGoogle Scholar
• Gutmann, D. H., A. C. Hirbe, Z. Y. Huang, and C. A. Haipek. 2001. The protein 4.1 tumor suppressor, DAL-1, impairs cell motility, but regulates proliferation in a cell-type-specific fashion. Neurobiol. Dis. 8:266–278.
   PubMed Web of Science ®Google Scholar
• Heinrich, B., C. Hartmann, A. O. Stemmer-Rachamimov, D. N. Louis, and M. MacCollin. 2003. Multiple meningiomas: Investigating the molecular basis of sporadic and familial forms. Int. J. Cancer 103:483–488.
   PubMed Web of Science ®Google Scholar
• Hori, T., E. Takahashi, D. Ayusawa, K. Takeishi, S. Kaneda, and T. Seno. 1990. Regional assignment of the human thymidylate synthase (TS) gene to chromosome band 18p11.32 by nonisotopic in situ hybridization. Hum. Genet. 85:576–580.
   PubMedGoogle Scholar
• Jackson, E. L., N. Willis, K. Mercer, R. T. Bronson, D. Crowley, R. Montoya, T. Jacks, and D. A. Tuveson. 2001. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev. 15:3243–3248.
   PubMed Web of Science ®Google Scholar
• Johnson, C. V., D. E. Cool, M. B. Glaccum, N. Green, E. H. Fischer, A. Bruskin, D. E. Hill, and J. B. Lawrence. 1993. Isolation and mapping of human T-cell protein tyrosine phosphatase sequences: localization of genes and pseudogenes discriminated using fluorescence hybridization with genomic versus cDNA probes. Genomics 16:619–629.
   PubMedGoogle Scholar
• Kawakami, K., Y. Ishida, K. D. Danenberg, K. Omura, G. Watanabe, and P. V. Danenberg. 2002. Functional polymorphism of the thymidylate synthase gene in colorectal cancer accompanied by frequent loss of heterozygosity. Jpn. J. Cancer Res. 93:1221–1229.
   PubMedGoogle Scholar
• Kittiniyom, K., M. Mastronardi, M. Roemer, W. A. Wells, E. R. Greenberg, L. Titus-Ernstoff, and I. F. Newsham. 2004. Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation. Genes Chromosomes Cancer 40:190–203.
   PubMedGoogle Scholar
• Kuns, R., J. L. Kissil, I. F. Newsham, T. Jacks, D. H. Gutmann, and L. S. Sherman. 20 June 2005. Protein 4.1B expression is induced in mammary epithelial cells during pregnancy and regulates their proliferation. Oncogene doi:10.1038/sj.onc.1208813.
   Google Scholar
• Parra, M., P. Gascard, L. D. Walensky, J. A. Gimm, S. Blackshaw, N. Chan, Y. Takakuwa, T. Berger, G. Lee, J. A. Chasis, S. H. Snyder, N. Mohandas, and J. G. Conboy. 2000. Molecular and functional characterization of protein 4.1B, a novel member of the protein 4.1 family with high level, focal expression in brain. J. Biol. Chem. 275:3247–3255.
   PubMedGoogle Scholar
• Perry, A., D. X. Cai, B. W. Scheithauer, P. E. Swanson, C. M. Lohse, I. F. Newsham, A. Weaver, and D. H. Gutmann. 2000. Merlin, DAL-1, and progesterone receptor expression in clinicopathologic subsets of meningioma: a correlative immunohistochemical study of 175 cases. J. Neuropathol. Exp. Neurol. 59:872–879.
   PubMed Web of Science ®Google Scholar
• Peters, L. L., H. U. Weier, L. D. Walensky, S. H. Snyder, M. Parra, N. Mohandas, and J. G. Conboy. 1998. Four paralogous protein 4.1 genes map to distinct chromosomes in mouse and human. Genomics 54:348–350.
   PubMedGoogle Scholar
• Robb, V. A., W. Li, P. Gascard, A. Perry, N. Mohandas, and D. H. Gutmann. 2003. Identification of a third protein 4.1 tumor suppressor, protein 4.1R, in meningioma pathogenesis. Neurobiol. Dis. 13:191–202.
   PubMed Web of Science ®Google Scholar
• Sage, J., G. J. Mulligan, L. D. Attardi, A. Miller, S. Chen, B. Williams, E. Theodorou, and T. Jacks. 2000. Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization. Genes Dev. 14:3037–3050.
   PubMed Web of Science ®Google Scholar
• Scholzen, T., and J. Gerdes. 2000. The Ki-67 protein: from the known and the unknown. J. Cell Physiol. 182:311–322.
   PubMed Web of Science ®Google Scholar
• Shi, Z. T., V. Afzal, B. Coller, D. Patel, J. A. Chasis, M. Parra, G. Lee, C. Paszty, M. Stevens, L. Walensky, L. L. Peters, N. Mohandas, E. Rubin, and J. G. Conboy. 1999. Protein 4.1R-deficient mice are viable but have erythroid membrane skeleton abnormalities. J. Clin. Investig. 103:331–340.
   PubMedGoogle Scholar
• Sun, C. X., V. A. Robb, and D. H. Gutmann. 2002. Protein 4.1 tumor suppressors: getting a FERM grip on growth regulation. J. Cell Sci. 115:3991–4000.
   PubMed Web of Science ®Google Scholar
• Tchernia, G., N. Mohandas, and S. B. Shohet. 1981. Deficiency of skeletal membrane protein band 4.1 in homozygous hereditary elliptocytosis. Implications for erythrocyte membrane stability. J. Clin. Investig. 68:454–460.
   PubMed Web of Science ®Google Scholar
• Tran, Y., K. Benbatoul, K. Gorse, S. Rempel, A. Futreal, M. Green, and I. Newsham. 1998. Novel regions of allelic deletion on chromosome 18p in tumors of the lung, brain and breast. Oncogene 17:3499–3505.
   PubMedGoogle Scholar
• Tran, Y. K., O. Bogler, K. M. Gorse, I. Wieland, M. R. Green, and I. F. Newsham. 1999. A novel member of the NF2/ERM/4.1 superfamily with growth suppressing properties in lung cancer. Cancer Res. 59:35–43.
   PubMed Web of Science ®Google Scholar
• Uchida, K., K. Hayashi, K. Kawakami, S. Schneider, J. M. Yochim, H. Kuramochi, K. Takasaki, K. D. Danenberg, and P. V. Danenberg. 2004. Loss of heterozygosity at the thymidylate synthase (TS) locus on chromosome 18 affects tumor response and survival in individuals heterozygous for a 28-bp polymorphism in the TS gene. Clin. Cancer Res. 10:433–439.
   PubMed Web of Science ®Google Scholar
• Yamakawa, H., and O. Ohara. 2000. Comparison of mRNA and protein levels of four members of the protein 4.1 family: the type II brain 4.1/4.1B/KIAA0987 is the most predominant member of the protein 4.1 family in rat brain. Gene 248:137–145.
   PubMedGoogle Scholar
• Ye, K., D. A. Compton, M. M. Lai, L. D. Walensky, and S. H. Snyder. 1999. Protein 4.1N binding to nuclear mitotic apparatus protein in PC12 cells mediates the antiproliferative actions of nerve growth factor. J. Neurosci. 19:10747–10756.
   PubMedGoogle Scholar
• Ye, K., K. J. Hurt, F. Y. Wu, M. Fang, H. R. Luo, J. J. Hong, S. Blackshaw, C. D. Ferris, and S. H. Snyder. 2000. Pike. A nuclear gtpase that enhances PI3kinase activity and is regulated by protein 4.1N. Cell 103:919–930.
   PubMed Web of Science ®Google Scholar
• Yu, T., V. A. Robb, V. Singh, D. H. Gutmann, and I. F. Newsham. 2002. The 4.1/ezrin/radixin/moesin domain of the DAL-1/protein 4.1B tumour suppressor interacts with 14-3-3 proteins. Biochem. J. 365:783–789.
   PubMedGoogle Scholar